-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Upgrades Rigel Pharmaceuticals to Buy, Raises Price Target to $42

Benzinga·11/05/2025 22:10:54
Listen to the news
Jefferies analyst Eun Yang upgrades Rigel Pharmaceuticals (NASDAQ:RIGL) from Hold to Buy and raises the price target from $23 to $42.